Article info
Unexpected outcome (positive or negative) including adverse drug reactions
Case report
Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis
- Correspondence to Dr Ross Leader, rossleader{at}doctors.org.uk
Citation
Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosis
Publication history
- Accepted September 5, 2019
- First published September 19, 2019.
Online issue publication
September 19, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.